Home
Orbimed Advisors reported a 9.5% stake in Enliven Therapeutics ELVN · 6,774,507 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 9.5%
- Last report
- 10.93% · filed 26/06/17
- Shares held
- 6,774,507 sh
- Class
- COMMON STOCK
- Holder
- Orbimed Advisors
- Event date
- 26/06/22
- Filed
- 26/06/24
9.5% stake · −1.4pp from the last report
- Stake
- 9.5%
- Last report
- 10.93%
- Since last report
- −1.4pp
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 05/23~07/22Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
- Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stakeWhitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14
